Paid Clinical Trials in Sandusky, OH
As of July 2026, 17 paid clinical trials are recruiting in Sandusky, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Sandusky offers studies at sites including North Coast Cancer Care for conditions such as Metastatic Malignant Neoplasm in the Brain, Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Sandusky
Trials by drug in Sandusky
Filter results
Newly added in Sandusky
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
17 clinical trials
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Top Research Study Locations in Sandusky
Researchers run research studies in Sandusky, OH at 7 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| North Coast Cancer Care | Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Cardiotoxicity | 8 |
| UH Seidman Cancer Center at Firelands Regional Medical Center | Acral Lentiginous Melanoma, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | 4 |
| Cleveland Clinic Cancer Centers Sandusky | Colorectal Neoplasms | 1 |
| Erie Shores Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Local Institution - 0438 | Non-Small Cell Lung Cancer | 1 |
| University Hospitals Seidman Cancer Center | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| University of Hospitals North Ohio Heart | Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
Active & Upcoming Studies in Sandusky (2026)
Recruiting trials in Sandusky grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer · Phase 3 · Gilead Sciences
Cardiovascular (1 active study)
Common conditions studied in Sandusky
- Metastatic Malignant Neoplasm in the Brain (2 active studies)
- Acral Lentiginous Melanoma (1 active study)
- Anatomic Stage IV Breast Cancer AJCC v8 (1 active study)
- Breast Cancer (1 active study)
- Cardiotoxicity (1 active study)
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8 (1 active study)
Leading research sponsors in Sandusky
- NRG Oncology
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Bristol-Myers Squibb
- Cytokinetics
Frequently asked questions
How many paid clinical trials are currently recruiting in Sandusky?
There are approximately 17 recruiting clinical trials in Sandusky, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Sandusky pay participants?
Most recruiting trials in Sandusky compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Sandusky?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Sandusky?
The most common conditions under active study in Sandusky include Metastatic Malignant Neoplasm in the Brain (2), Acral Lentiginous Melanoma (1), Anatomic Stage IV Breast Cancer AJCC v8 (1), Breast Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Sandusky?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Sandusky on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Sandusky?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Sandusky?
Recruiting research sites in Sandusky include North Coast Cancer Care, UH Seidman Cancer Center at Firelands Regional Medical Center, Cleveland Clinic Cancer Centers Sandusky, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Sandusky right now?
The largest active categories in Sandusky are Cancer & tumors (14), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.